Vancomycin-resistant staphylococcus aureus - New York, 2004

Morbidity and Mortality Weekly Report

Volumn 53, Issue 15, 2004, Pages 322-323

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; DRUG EFFECT; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

CROSS INFECTION; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; NEW YORK; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 2142751063     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. CDC. National Nosocomial Infections Surveillance (NNIS) report, data summary from January 1992-June 2001. Am J Infect Control 2001;29:404-21.
2. Lowy F. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32.
3. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard, M7-A6. Wayne, Pennsylvania: National Committee for Laboratory Standards, 2003.
4. CDC. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR 2002;51:565-7.
5. CDC. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR 2002;51:902.
6. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-7.
7. Whitener CJ, Park SY, Browne FA, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 2004;38:1049-55.